ORBIS
Published: 2020-03-31

ORBIS (Open Research Biopharmaceutical Internships Support) – building bridges between academia and pharmaceutical industry to improve drug development

Chair and Department of Pharmaceutical Technology, Faculty of Pharmacy, Poznan University of Medical Sciences, Poznan
Applied Process Consulting Ltd., Dublin, Ireland
Zentiva k.s., Prague, Czech Republic
Physiolution GmbH, Greifswald, Germany
University of Helsinki, Division of Pharmaceutical Chemistry and Technology, Formulation and Industrial Pharmacy Unit, Helsinki, Finland
Center for Dermal Research and Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA
Łukasiewicz Research Network – Pharmaceutical Research Institute, Warsaw, Poland
Institute of Technology and Chemical Engineering, Poznan University of Technology, Poznan, Poland
University of Helsinki, Division of Pharmaceutical Chemistry and Technology, Formulation and Industrial Pharmacy Unit, Helsinki, Finland
JSC Farmak, Kyiv, Ukraine
School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, College Green, Dublin 2
Chair and Department of Pharmaceutical Technology, Faculty of Pharmacy, Poznan University of Medical Sciences, Poznan, Poland
Bio
×

Janina Lulek

Chair and Department of Pharmaceutical Technology
Poznan University of Medical Sciences
Grunwaldzka 6 st.
60-780 Poznan, Poland,
jlulek@ump.edu.pl
phone + 48 61 854 66 60, fax +48 61 854 66 66

drug discovery and design pharmaceutical formulation research and development solid state materials pharmaceutical technology biomedical analysis

Abstract

Open Research Biopharmaceutical Internships Support (ORBIS) is an international, Horizon 2020 project funded by Maria Skłodowska-Curie Actions, Research and Innovation Staff Exchange (RISE) programme. Six academic institutions and four pharmaceutical companies from seven countries cooperate with the aim to improve the preclinical pathway of medicine development through increased Research and Development (R&D) productivity, especially focusing on processes and technologies which address the challenge of poor drug bioavailability. The RISE scheme supports secondments, meaning that early stage and experienced researchers are sent to consortium partner institutions to advance studies on pharmaceutical preformulation, dosage forms and drug delivery systems and methods of biopharmaceutical evaluation. The ORBIS project enables secondees to gain news skills and develop their competences in an international and intersectoral environment, strengthening the human capital and knowledge synergy in the European pharmaceutical R&D sector.

Downloads

Download data is not yet available.

How to Cite

1.
Jakubowska E, Davin S, Dumicic AD, Garbacz G, Juppo A, Michniak-Kohn B, Rudzki PJ, Smułek W, Strachan C, Syarkevych O, Tajber L, Lulek J. ORBIS (Open Research Biopharmaceutical Internships Support) – building bridges between academia and pharmaceutical industry to improve drug development. JMS [Internet]. 2020Mar.31 [cited 2020Aug.8];89(1):e419. Available from: https://jms.ump.edu.pl/index.php/JMS/article/view/419